Bottom Line Medicine is written to inform the public of the latest findings in the field of evidence-based medicine. Recounting the costs and the risks of hospitalization and various treatment options, it reveals the lack of research to support the majority of medical therapies, exposes the profit motive so prevalent throughout medicine, and the double standard applied to alternative therapies. Massively documented with statistics and charts as well as examples from numerous US and international studies, the book reviews the same medical literature used by physicians, providing head to head comparisons of the outcomes of medical intervention versus healthy living.
Richard Stanzak is a critical care nurse. He also worked as a molecular biologist for fourteen years, seven of them for Eli Lilly pharmaceuticals in both research and development.
As a traveling ICU nurse he has been employed at 19 different assignments. He has worked in major trauma units, transplant units, cardiac units and hospitals from 1150 beds to 8 beds. He has experienced first-hand the problems of healthcare and can certainly attest this is a national problem.
Stanzak is the author and/or co-author of several papers and also has several patents. He is the lead author of a benchmark paper on the cloning of genes responsible for the production of erythromycin. He was engaged in research at Eli Lilly when Prozac was first discovered and Genentech first licensed the insulin gene to Lilly. As a critical care nurse, he is responsible for providing teaching to patients or families about drugs, diseases and procedures.